and clinical research services

Search documents
What to Expect From IQVIA Holdings’ Next Quarterly Earnings Report
Yahoo Finance· 2025-10-15 08:25
Durham, North Carolina-based IQVIA Holdings Inc. (IQV) is a global leader in healthcare data, analytics, technology, and clinical research services. With a market cap of $34.6 billion, the company operates across three main segments, Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions, serving pharmaceutical, biotech, and healthcare clients in over 100 countries. IQV is scheduled to report its Q3 earnings before the market opens on Tuesday, Oct. 28. A ...
ILMN Stock vs. IQV Stock
Forbes· 2025-09-26 13:40
Group 1 - Illumina's stock has dropped by 11% in a week due to increased competition from China's MGI Tech, which is gaining market share in DNA sequencing [2] - MGI Tech's global market presence remains strong despite a recent decline in international sales due to U.S. sanctions [2] - IQVIA presents stronger revenue growth at 5.3% compared to Illumina's decline of 4.8%, indicating a potentially better investment opportunity [3][6] Group 2 - Illumina offers solutions for genomic analysis and sequencing, serving research and clinical markets globally [4] - IQVIA provides advanced analytics and clinical research services, including cloud applications and project management for the life sciences sector [4] - IQVIA's revenue growth for the last 12 months is 3.6%, surpassing Illumina's -3.3%, and IQVIA's average margin is 13.7% compared to Illumina's 6.7% [6]